A staph infection is a type of skin infection that occurs by bacteria ... a staph infection may develop into methicillin-resistant Staphylococcus aureus, or MRSA, which can become deadly as ...

Uncomplicated skin infections account for almost 200 million ... The primary etiology of these infections is Staphylococcus aureus, over 60% of which is estimated to be methicillin resistant ...

Staph infections are caused by Staphylococcus bacteria, most commonly the Staphylococcus aureus strain. These bacteria often ...

cSSSI: Complicated skin and skin-structure infection; ESBL: Extended spectrum β lactamase; MRSA: Methicillin-resistant Staphylococcus aureus; MSSA: Methicillin-susceptible Staphylococcus aureus.

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...

Staphylococcus aureus (S. aureus) is a major cause of skin and soft tissue infections that can sometimes lead to sepsis and toxic shock syndrome. The microbe poses a significant threat to public ...

is designed to prevent skin and soft tissue infections caused by the bacterial pathogen. There are currently no FDA-approved vaccines for Staph aureus infections, according to a Dec. 19 news release.

Skin swabs taken from eczema ... tool – to kill bad bacteria like Staphylococcus aureus before they’re able to cause problematic infections. Dr Bjorn Herpers, medical advisor to Micreos ...

Methicillin-resistant Staphylococcus aureus (MRSA ... the bacteria can sometimes enter a break in the skin, causing a serious infection that requires immediate treatment. In the early stages ...

Any one of those mutations could give your staph infection the capacity to continue replicating, even in the presence of the antibiotic. All it takes is a single mutated S. aureus—one that ...

After dozens of clinical trials, there are still no effective vaccines against Staphylococcus aureus ... particularly effective at fighting S. aureus infections. But by blocking IL-10 or adding ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...